Arlo N. McGinn, Ph.D. - Publications

2013 Pharmacology and Toxicology University of Utah, Salt Lake City, UT 
Pharmacy, Pharmacology, Genetics

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Lee Y, McGinn AN, Olsen CD, Nam K, Lee M, Shin SK, Kim SW. Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 24-32. PMID 23806842 DOI: 10.1016/J.Jconrel.2013.06.022  0.399
2013 Won YW, McGinn AN, Lee M, Nam K, Bull DA, Kim SW. Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Biomaterials. 34: 6229-38. PMID 23714244 DOI: 10.1016/J.Biomaterials.2013.04.061  0.371
2013 Won YW, McGinn AN, Lee M, Bull DA, Kim SW. Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier. Molecular Pharmaceutics. 10: 378-85. PMID 23214982 DOI: 10.1021/Mp300500Y  0.405
2011 McGinn AN, Nam HY, Ou M, Hu N, Straub CM, Yockman JW, Bull DA, Kim SW. Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials. 32: 942-9. PMID 20970850 DOI: 10.1016/J.Biomaterials.2010.09.061  0.391
2010 Nam HY, McGinn A, Kim PH, Kim SW, Bull DA. Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials. 31: 8081-7. PMID 20674007 DOI: 10.1016/J.Biomaterials.2010.07.025  0.333
Show low-probability matches.